Human Vaccines Project Launches Study of How the Immune System Responds to the Flu
The Human Vaccine Project aims to understand how the human immune system can develop longer-lasting protection against influenza.
Common Misconceptions Are the Cause for Almost Half of U.S. Adults Skipping the Flu Shot
A new survey shows more than 40 percent of Americans haven’t been vaccinated against the flu and aren’t planning to be due to misconceptions.
Severe Flu Increases Risks for Pregnant Women and Their Babies
A new study shows pregnant women hospitalized in the ICU with flu are four times more likely to deliver prematurely and four-and-a-half times more likely to have a baby of low birth weight.
CDC OKs FluMist for 2018-19 Influenza Season
The Centers for Disease Control and Prevention’s advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza (flu) season.
Cell-Based and Recombinant Vaccines More Effective in 2017-18 Flu Season
New data shows cell-based and recombinant vaccines were more effective in the 2017-18 influenza (flu) season
Heart Failure Death Risk Drops 50% in Those Who Receive Flu Vaccine
A new study shows people with heart failure who receive a seasonal influenza (flu) vaccine have a 50 percent drop in the risk of death during flu season and a 20percent drop in the risk of death during the rest of the year.
FDA Chooses Influenza Vaccine Strains for the 2018-19 Season
The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee chose the Northern Hemisphere’s 2018-19 influenza (flu) vaccine strains based on the World Health Organization’s recommendations.
Flu Vaccine Recommendations Updated by CDC and AAP
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices has updated its 2017-18 recommendations regarding the use of seasonal influenza (flu) vaccines and guidance for vaccine providers about the use of flu vaccines for the 2018-19 season.
FDA Chooses Influenza Vaccine Strains for the 2018-19 Seasons
FDA’s Vaccines and Related Biological Products Advisory Committee chose the Northern Hemisphere’s 2018-19 influenza (flu) vaccine strains based on the World Health Organization’s recommendations.
CDC OKs FluMist for 2018-19 Influenza Season
The Centers for Disease Control and Prevention advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza (flu) season.
